The 2019 Benchmarking Pharma Partnering in Europe report outlines how deals are flowing in Europe, noting partnerships in this region don’t come without their costs.
We analyzed 43 pharmaceutical licensing deals between January 2012 and August 2019, in which Europe was the major territory for a foreign partner.
Some of the details in the report include:
Discover if partnering in China will be worthwhile for your company.
Get the PDF:
What's a Deal Worth? Benchmarking Pharma Partnering in Europe